European Modular Education and Training Programme in Safety Sciences for Medicines

Training the next generation of Safety Scientists in Europe.

Funding: The project is receiving support from the Innovative Medicines Initiative Joint Undertaking, resources of which are composed of financial contribution from the EU's 7th Framework Programme and EFPIA companies.

Timeline: 2012-2017

Description: SafeSciMET has established a new and unique pan-European education and training network, providing master’s level courses in safety sciences for medicines. The training has focus on holistic, integrative and translational approaches.

Biopeople's role:
Couse Director. Biopeople / University of Copenhagen is involved in the training course concerning regulatory aspects of safety sciences.

Project Partners:

• VU University Amsterdam
• University of Konstanz
• University of Surrey
• EUFEPS
• Uppsala University
• University of Copenhagen
• Universiteit Leiden
• Universite de Lorraine
• Martin-Luther-University
• HalleKarolinska Institutet Stockholm
• University of Vienna
• Universite de Paris-Sud
• MRC Centre for Drug Safety Science
• Universidade de Lisboa
• Charite University Medicine Berlin
• Almirall
• AstraZeneca Ltd
• Bayer-Schering Pharma AG
• Boehringer-Ingelheim Pharma
• Eli-Lilly Ltd
• GlaxoSmithKline Ltd
• F. Hoffmann-La Roche
• Lundbeck A/S
• Merck KGaA
• Novartis Pharma AG
• Novo Nordisk A/S
• Orion Pharma
• Sanofi
• UCB Pharma S.A.

External URL